This trial studies how a drug affects people with different kidney function levels.
- Kidney Disease
- Kidney Failure
3 Primary · 5 Secondary · Reporting Duration: Days 1 - 5
Side Effects for
4 Treatment Groups
Group 1: Severe Hepatic Impairment
1 of 4
Group 2: Moderate Hepatic Impairment
1 of 4
Group D: Normal Hepatic Function
1 of 4
Group 3: Mild Hepatic Impairment
1 of 4
30 Total Participants · 4 Treatment Groups
Primary Treatment: Group 1: Severe Hepatic Impairment · No Placebo Group · Phase 1
Participation is compensated
You will be compensated for participating in this trial.
Who is running the clinical trial?
Age 18 - 80 · All Participants · 6 Total Inclusion CriteriaMark “Yes” if the following statements are true for you:
Frequently Asked Questions
Is enrollment for this experiment open to participants yet?
"Affirmative. Clinicaltrials.gov has documentation that this clinical trial, first announced on February 26th of 2023, is seeking applicants at the moment. 30 subjects are needed from 3 separate locations to complete the study's requirements." - Anonymous Online Contributor
What goals is this study attempting to achieve?
"This trial, which is set to be evaluated over a five-day period, seeks to evaluate the Area Under Curve of INCB054707. Secondary endpoints include number of Treatment Emergent Adverse Events (TEAEs), apparent oral dose volume of distribution and oral dose clearance associated with INCB054707." - Anonymous Online Contributor
Has the FDA sanctioned Group 1: Severe Hepatic Impairment as a safe treatment?
"The safety of Group 1: Severe Hepatic Impairment was rated as a 1, given that the clinical trial is in Phase 1 and only has limited evidence supporting its efficacy and security." - Anonymous Online Contributor
Does the criteria for this research include those beyond 55 years of age?
"The age range for inclusion into this research is between 18 and 80. There are 46 trials designed specifically to cater to those under the age of majority, whereas 563 clinical studies accommodate seniors above 65 years old." - Anonymous Online Contributor
How many individuals are currently participating in this research study?
"Affirmative. According to clinicaltrials.gov, this investigation is recruiting patients currently and was posted on the 26th of February 2023 with its last update occuring on the 15th November 2022. A total of 30 subjects must be found from 3 different locations for inclusion in the trial." - Anonymous Online Contributor
Would I be eligible to participate in this research endeavor?
"This clinical trial has a participant requisition of 30 people, whose eligibility is determined by their age (18-80) and kidney failure status." - Anonymous Online Contributor